ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | — |
Budget/Appropriations BUD
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government H.R. 133, Consolidated Appropriations Act 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | — |
| NEAL PATEL | COS to Deputy Dir. for Mgmt., OMB (EOP); Deputy Assoc. Dir. for Leg Affairs, OMB (EOP); Professional Staff Member, Senate Finance Cmte; Communications Dir. & Counsel, Senator Dean Heller; Communications Dir. & Counsel, Rep. Charles Boustany, Jr.; Com |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.